NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

Inicio・Lista de Acciones・Roche Holding AG

Roche Holding AG

Cerrado

SectorSanidad

330.4 0.85

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

330

Máximo

334.6

Métricas clave
By Trading Economics
Ingresos	1.8B 5.5B
Ventas	15B 31B
P/B Media del Sector	20.312 51.415
Rentabilidad por dividendo	3
Margen de beneficios	17.892
Empleados	103,249
EBITDA	5.1B 12B

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	3.00% 2.34%

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-30B 259B
Apertura anterior	329.55
Cierre anterior	330.4

Noticias sobre sentimiento de mercado

By Acuity

45%

55%

139 / 345 Clasificación en Healthcare

Roche Holding AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 may 2026, 06:06 UTC

Adquisiciones, fusiones, absorciones

Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools

23 abr 2026, 07:46 UTC

Ganancias

Roche Backs Full-Year View as Quarterly Sales Rise -- Update

23 abr 2026, 05:40 UTC

Ganancias

Roche Backs Full-Year View as Quarterly Sales Rise

9 mar 2026, 16:43 UTC

Principales Movimientos del Mercado

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study -- Update

9 mar 2026, 15:44 UTC

Principales Movimientos del Mercado

Correction to Roche Shares Article

9 mar 2026, 09:51 UTC

Principales Movimientos del Mercado

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

6 mar 2026, 09:24 UTC

Principales Movimientos del Mercado

Zealand Pharma Shares Plunge After Obesity Drug Candidate Disappoints in Trial

13 may 2026, 10:20 UTC

Charlas de Mercado

Ganancias

Roche Strikes Upbeat Tone on Long-Term Outlook -- Market Talk

7 may 2026, 05:53 UTC

Adquisiciones, fusiones, absorciones

Correct: Roche to Buy PathAI for up to $1.05B

7 may 2026, 05:07 UTC

Adquisiciones, fusiones, absorciones

Roche: Acquisition Expected to Complete in 2H

7 may 2026, 05:06 UTC

Adquisiciones, fusiones, absorciones

Roche: Closing of Deal Subject to Customary Closing Conditions

7 may 2026, 05:06 UTC

Adquisiciones, fusiones, absorciones

Roche to Pay $750M Upfront, Milestone Payments of Up to $300M

7 may 2026, 05:06 UTC

Adquisiciones, fusiones, absorciones

Roche to Buy PathAI for up to $1.5B

7 may 2026, 05:05 UTC

Adquisiciones, fusiones, absorciones

Roche to Buy PathAI

6 may 2026, 22:50 UTC

Ganancias

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

27 abr 2026, 09:54 UTC

Charlas de Mercado

Roche's Vabysmo U.S. Recovery Will Be Key -- Market Talk

23 abr 2026, 08:10 UTC

Charlas de Mercado

Ganancias

Roche Reports In Line Sales Figures -- Market Talk

23 abr 2026, 05:04 UTC

Ganancias

Roche Backs 2026 View

23 abr 2026, 05:04 UTC

Ganancias

Roche Diagnostics Division 1Q Sales Up at 3% Constant Currency

23 abr 2026, 05:03 UTC

Ganancias

Roche Pharmaceutical Division 1Q Sales Up 7% at Constant Currency

23 abr 2026, 05:02 UTC

Ganancias

Roche 1Q Group Sales Up 6% at Constant Currency

23 abr 2026, 05:02 UTC

Ganancias

Analysts Saw Roche 1Q Sales at CHF14.73B

23 abr 2026, 05:01 UTC

Ganancias

Roche 1Q Sales CHF14.72B

10 abr 2026, 11:28 UTC

Charlas de Mercado

Roche's Longer-Term Outlook to Take Spotlight at Diagnostics Event -- Market Talk

10 abr 2026, 11:17 UTC

Charlas de Mercado

Roche to Face Significant Currency Headwinds -- Market Talk

11 mar 2026, 10:57 UTC

Charlas de Mercado

Roche Sees Mixed Fortunes in Immunology, Oncology -- Market Talk

9 mar 2026, 09:43 UTC

Acciones populares

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

6 mar 2026, 07:22 UTC

Charlas de Mercado

Roche, Zealand Pharma Obesity Drug Falls Short of Expectations -- Market Talk

3 mar 2026, 07:22 UTC

Charlas de Mercado

Roche's Multiple Sclerosis Drug Safety Remains in Focus After Latest Trial -- Market Talk

2 mar 2026, 14:21 UTC

Charlas de Mercado

Roche's Multiple Sclerosis Drug Might Not Clear FDA Bar -- Market Talk

Comparación entre iguales

Cambio de precio

Roche Holding AG previsión

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Roche Holding AG Dist en los últimos 3 meses.

Sentimiento

By Acuity

139 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Otras acciones del sector

NOVN.CH

Novartis AG

117.02

↑ +0.26%

Roche Holding AG

Resumen

Variación precio

Métricas clave

Dividendos

Estadísticas de Mercado

Noticias sobre sentimiento de mercado

Roche Holding AG Gráfico

Noticias Relacionadas

Comparación entre iguales

Roche Holding AG previsión

Consenso

Sentimiento

Finanzas

Acerca de Roche Holding AG

Otras acciones del sector